13 results
Antiarrhythmic Medication Table

#Antiarrhythmic #Medications #Table #Classification #Classes #Cardiology #Pharmacology
Antiarrhythmic Medication ... Table #Antiarrhythmic ... #Medications #Table ... Classification #Classes ... #Cardiology #Pharmacology
Antiarrhythmic Medications - Vaughan Williams Classification - Summary Table
Class I agents - Sodium Channel Blockers⠀
Class II
Antiarrhythmic Medications ... Classification - Summary ... Table Class I agents ... #Summary #Table ... #pharmacology #
Common Medications Known to Prolong QTc
Antiarrhythmics - Amiodarone, sotalol, flecainide, quinidine, dronedarone, dofetilide
Vasopressors/inotropes - Epinephrine, norepinephrine,
Common Medications ... to Prolong QTc Antiarrhythmics ... #Causes #differential ... #diagnosis #pharmacology ... #table
Antiplatelet Medications - Summary Table

Aspirin - Inhibits cyclooxygenase, preventing formation of thromboxane A2
 • Acute coronary
Antiplatelet Medications ... - Summary Table ... Inhibits the P2Y12 ADP ... #Summary #Table ... #Pharmacology
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
4 Inhibitors - Pharmacology ... Summary Mechanisms ... not definitively cause ... DPP4 #Inhibitors #Pharmacology ... #Summary #DM2 #
Summary of β-adrenergic antagonists
 - Propranolol - Beta1, Beta2 - Hypertension, Migraine, Hyperthyroidism, Angina pectoris 
-
Summary of β-adrenergic ... #BetaBlockers #Pharmacology ... #Table #Uses #Applications ... #Indications
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
- Pharmacology ... Summary Mechanisms ... Ozempic), or daily tablet ... not definitively cause ... #Summary #DM2 #
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Type 2 Inpatient Medication ... Guide Classes ... DPP-4 inhibitor, GLP ... #pharmacology # ... comparison #table
Summary of meta-analysis of pharmacotherapy trials in BPD
https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder
Meta-analyses of RCTs were undertaken for the following outcomes:
Summary of meta-analysis ... for inclusion all ... EBM #Management #Pharmacology ... Personality #Disorder #Medications ... Effectiveness #Table
Antiarrhythmics Pharmacology Summary
Cardiac Conduction Phases:
Phase 0 - Ventricular Depolarization:
 • Na+ channels open leading to a
Antiarrhythmics ... Pharmacology Summary ... @accpcardprn #Antiarrhythmics ... #Pharmacology # ... Classification #Classes